How the brain's little blue dot regulates your sleep
The locus coeruleus is emerging as a major new area of research interest, with many important functions such as regulating ...
Your IBS May Be a Brain Problem – And Researchers Have the Answer
A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...
Rethinking metastatic brain cancer as a central nervous system disease
A Personal View published in The Lancet Oncology challenges the long-standing perception of metastatic brain cancer, calling ...
Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation
Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central ...
News Medical on MSN7d
New drug class may help alleviate IBS symptoms by targeting the central nervous system
Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, ...
Data analytics startup Athenic AI wants to be an enterprise’s central nervous system
The result was Athenic AI, a company that uses AI to run data analytics for enterprises across all of their data sources.
News Medical on MSN5d
Opioid δ-receptor agonists show promise for treating IBS-like symptoms
Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
EurekAlert!7d
Beyond the gut: A new frontier in IBS treatment by targeting the brain
Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global ...
The Malta Independent3d
Strengthen your central nervous system with Neuralta Brain Power
Neuralta Brain Power by Alta Care Laboratoires is an innovative liquid capsule supplement designed to support and strengthen the central nervous system, which is crucial for cognitive ...
NLS Pharmaceutics and Kadimastem Unveil Multi-Target Approach to Diabetes, Expanding Beyond GLP-1 Therapies
NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous ...